Co-founder of Exeliom Biosciences and Chief Medical Officer ad interim
Professor at the Gastroenterology department of the Saint Antoine Hospital in Paris, France.
Head of the Gut Microbiome laboratory at the Sorbonne University.
Internationally renowned expert in Inflammatory Bowel Disease (IBD) and the gut microbiome, with over 200 publications in these fields. Involved in translational research, and current president of the French group Faecal Microbiota Transplantation.
His research on the commensal bacterium Faecalibacterium prausnitzii led to the foundation of the company.